DNA and Oxidative Damages Decrease After Ingestion of Folic Acid in Patients with Type 2 Diabetes

Archives of Medical Research

Volumn 43, Issue 6, 2012, Pages 476-481

  Lazalde Ramos, Blanca Patricia ^a   Zamora Perez, Ana Lourdes ^b   Sosa Macías, Martha ^c   Guerrero Velázquez, Celia ^b   Zúñiga González, Guillermo Moises ^d  

^a UNIVERSIDAD AUTÓNOMA DE ZACATECAS   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Diabetes mellitus; Folic acid; Micronuclei; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FOLIC ACID; LIPID PEROXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DNA DAMAGE; FEMALE; HUMAN; MALE; MICRONUCLEUS TEST; MOUTH MUCOSA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

ADULT; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; FOLIC ACID; HUMANS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84867880521     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.08.013     Document Type: Article

References (45)

1. LeRoit D., Taylor S.I., Olefssky J.M. Diabetes Mellitus. A Fundamental and Clinical Text 2003, Lippincott Publishers, Philadelphia. 3rd ed.
2. Singh P.P., Farzana M., Ajanta R., et al. Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem 2009, 24:324-342.
3. Porte D. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes Metab Res Rev 2001, 17:181-188.
4. Kashiwagi A., Asahina T., Nishio Y., et al. Oxidative stress and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 1996, 45:84-86.
5. Huebschmann A.G., Regensteiner J.G., Vlassara H., et al. Diabetes and advanced glycoxidation end products. Diabetes Care 2006, 29:1420-1432.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
7. Hoffbrand A.V., Weir D.G. The history of folic acid. Br J Haematol 2001, 113:579-589.
8. Slatter D.A., Bolton C.H., Bailey A.J. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000, 43:550-557.
9. Khan A., Lasker S.S., Chowdhury T.A. Are spouses of patients with type 2 diabetes at increased risk of developing diabetes?. Diabetes Care 2003, 26:710-712.
10. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
11. Podmore I.D., Cooper D., Evans M.D., et al. Simultaneous measurement of 8-oxo-2-deoxyguanosine and 8-oxo-2-deoxyadenosine by HPLC-MS/MS. Biochem Biophys Res Commun 2000, 277:764-770.
12. Fujino Y., Guo X., Liu J., et al. Chronic arsenic exposure and urinary 8-hydroxy-2'-deoxyguanosine in an arsenic-affected area in Inner Mongolia, China. J Expo Anal Environ Epidemiol 2005, 15:147-152.
13. Dandona P., Thusu K., Cook S., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
14. Lafleur M.V., Retel J. Contrasting effects of SH-compounds on oxidative DNA damage: repair and increase of damage. Mutat Res 1993, 295:1-10.
15. Yfjord J.E., Bodvarsdottir S.K. Genomic instability and cancer: networks involved in response to DNA damage. Mutat Res 2005, 592:18-28.
16. Heddle J.A., Cimino M.C., Hayashi M., et al. Micronuclei as an index of cytogenetic damage: past, present and future. Environ Mol Mutagen 1991, 18:227-291.
17. Schmid W. The micronucleus tests. Mutat Res 1975, 31:9-15.
18. Zúñiga-González G., Gómez-Meda B.C., Zamora-Perez A., et al. Induction of micronuclei in proestrus vaginal cells from colchicine- and cyclophosphamide-treated rats. Environ Mol Mutagen 2003, 42:306.
19. Torres-Bugarín O., Ventura-Aguilar A., Zamora-Perez A., et al. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. Mutat Res 2004, 565:91-101.
20. Bonassi S., Biasotti B., Kirsch-Volders M., et al. State of the art survey of the buccal micronucleus assay-a first stage in the HUMN (XL) project initiative. Mutagenesis 2009, 24:295-302.
21. Zúñiga-González G.M., Batista-González C.M., Gómez-Meda B.C., et al. Micronuclei in diabetes: folate supplementation diminishes micronuclei in diabetic patients but not in an animal model. Mutat Res 2007, 634:126-134.
22. Tolbert P.E., Shy C.M., Allen J.W. Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat Res 1992, 271:69-77.
23. Thomas P., Holland N., Bolognesi C., et al. Buccal micronucleus cytome assay. Nat Protoc 2009, 4:825-837.
24. Yagi K. Simple assay for the level of total lipid peroxides in serum of plasma. Methods Mol Biol 1998, 108:101-118.
25. Martínez-Pérez L.M., Cerda-Flores R.M., Gallegos-Cabriales E.C., et al. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med Rep 2007, 108:248-255.
26. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 2006, 103:17589-17594.
27. Fenech M. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 2001, 475:57-67.
28. Fenech M., Bonassi S. The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis 2011, 26:43-49.
29. Konopacka M. Effect of smoking and aging on micronucleus frequencies in human exfoliated buccal cells. Neoplasma 2003, 50:380-382.
30. Haveric A., Haveric S., Ibrulj S. Micronuclei frequencies in peripheral blood and buccal exfoliated cells of young smokers and non-smokers. Toxicol Mech Methods 2010, 20:260-266.
31. Zamani A.G., Durakbasi-Dursun H.G., Demirel S., et al. Evaluation of smoking genotoxicity in Turkish young adults. Indian. J Hum Genet 2011, 17:7-12.
32. Stich H.F., Rosin M.P. Quantitating the synergistic effect of smoking and alcohol consumption with the micronucleus test on human buccal muocosa cells. Int J Cancer 1983, 31:305-308.
33. MiloŠević-Djordjević O., StoŠić I., Grujičić D., et al. Cervical precancerous lesions-chromosomal instability in peripheral blood lymphocytes in relation to lesion stage, age and smoking habits. Acta Obstet Gynecol Scand 2011, 90:1082-1087.
34. Milosevic-Djordjevic O., Stosic I., Vuckovic M., et al. Baseline and therapy-induced chromosome damages in peripheral blood lymphocytes of breast cancer patients assessed by the micronucleus assay. J BUON 2011, 16:437-443.
35. Milosević-Djordjević O., Grujiciĉ D., Vaskoviĉ Z., et al. High micronucleus frequency in peripheral blood lymphocytes of untreated cancer patients irrespective of gender, smoking and cancer sites. Tohoku. J Exp Med 2010, 220:115-120.
36. Angelieri F., de Cássia Gonçalves Moleirinho T., Carlin V., et al. Biomonitoring of oral epithelial cells in smokers and non-smokers submitted to panoramic X-ray: comparison between buccal mucosa and lateral border of the tongue. Clin Oral Investig 2010, 14:669-674.
37. Nersesyan A., Muradyan R., Kundi M., et al. Impact of smoking on the frequencies of micronuclei and other nuclear abnormalities in exfoliated oral cells: a comparative study with different cigarette types. Mutagenesis 2011, 26:295-301.
38. Pan H.Z., Chang D., Feng L.G., et al. Oxidative damage to DNA and its relationship with diabetic complications. Biomed Environ Sci 2007, 20:160-163.
39. Hoeldtke R.D., Bryner K.D., Corum L.L., et al. Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA. Metabolism 2009, 58:731-734.
40. Goodarzi M.T., Navidi A.A., Rezaei M., et al. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J Clin Lab Anal 2010, 24:72-76.
41. Tabak O., Gelisgen R., Erman H., et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med 2011, 34:E163-E171.
42. Shettigar S.K., Shailaja C., Kulkarni R.K. Elevated micronuclei frequency in type 2 diabetes with high glycosylated hemoglobin. Diabetes Res Clin Pract 2012, 95:246-250.
43. Valavanidis A., Vlachogianni T., Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009, 27:120-139.
44. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipoperoxidation and peroxidative tissue injury. Free Radic Biol Med 1990, 9:515-540.
45. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997, 387:147-163.